Guangzhou Baiyunshan Pharmaceutical Announces Extraordinary General MeetingPUBT·Nov 12, 2026 at 11:51 AM00874-0.08%600332-1.12%
Mabwell tumbles 8% as Q3 loss widens on revenue declineMarket Movers·Oct 29, 2026 at 07:49 AM02493-0.73%
Mabwell's 9MW2821 Shows 30% Response Rate in Phase II Trial in ADC-Pretreated Triple-Negative Breast CancerPUBT·Oct 19, 2026 at 02:00 AM02493-0.73%688062-2.68%
What a Car Lender and a Biotech Are Doing in Hong Kong's "Internet" SectorGlobal Report·Oct 14, 2026 at 10:52 AM02473-0.46%02443+3.85%
AI Ads vs Paper Mills: Hong Kong's Internet Sector Identity Crisis ExposedGlobal Report·Oct 14, 2026 at 09:20 AM02493-0.73%01812-1.49%
Weekly Recap | MABWELL-B this week, a narrow low-volume rangeWeekly Review·Oct 10, 2026 at 05:23 AM02493-0.73%
Hong Kong Mid-Caps' Quiet Bet on AI Infrastructure: Power Plays and Chip MovesGlobal Report·Oct 6, 2026 at 09:17 AM00002+0.06%009980.00%
The AI Pharma Pivot: How Biotech Is Redrawing the Hong Kong Market MapGlobal Report·Sep 23, 2026 at 10:48 AM02493-0.73%09936-1.03%
Under-the-Radar Shifts: A Look Inside 6 Unclassified Tech and Bio StocksGlobal Report·Sep 23, 2026 at 09:14 AMKITT-17.70%SPRO-4.77%
HK Equities Q3 Movers: KE Holdings Posts Profit Jump as Energy and Consumer Sectors AdjustGlobal Report·Sep 15, 2026 at 10:12 AM00178-1.35%00991+0.20%
Biotech and SiC Startups Post Triple-Digit H1 Growth Amid Buoyant Gold ETF FlowGlobal Report·Sep 8, 2026 at 10:18 AM01300+4.33%020160.00%
Weekly Recap | MABWELL-B +0.29%, clinical data and interim results landWeekly Review·Sep 5, 2026 at 05:10 AM02493-0.73%
Mabwell Reports Positive COPD Data for 9MW1911 Ahead of ERS 2026Tip Ranks·Sep 4, 2026 at 03:09 PM02493-0.73%